Colgate-Palmolive Company CL is in a good spot, thanks to its robust business strategies. Strong pricing and funding-the-growth and other productivity initiatives have been bolstering the company’s ...

Colgate-Palmolive Company is poised to report its first-quarter results shortly, with analysts expecting modest single-digit ...

Colgate-Palmolive Company CL has been gaining from strong pricing, and the benefits of funding growth and other productivity efforts. The company’s aggressive pricing actions, along with solid ...

Deutsche Bank raised rating on shares Strong quarterly earnings surpassed consensus expectations recently Institutional ...

Colgate-Palmolive is a Dividend King with a 62-year record of dividend growth and global dominance in oral care products. CL recently rebounded from a multi-year earnings decline, driven by its 2022 ...

Colgate-Palmolive (NYSE:CL) has appointed Dr. Christopher S. Boerner, CEO and Board Chair of Bristol Myers Squibb, to its ...